3rd Quarter - Report

FOLEY HOAG LLP for SANOFI US SERVICES INC

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing

LobbyistCovered position, as disclosed
THOMAS BARKER —
BRIAN CAREY —
PAUL KIM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

-Issues related to H.R. 1625: "Consolidated Appropriations Act of 2018" -Issues related to H.R. 1892 "Bipartisan Budget Act of 2018" -Issues related to National Institute of Health funding -Issues related to Biomedical Advanced Research and Development Authority

LobbyistCovered position, as disclosed
BRIAN CAREY —
PAUL KIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1892 (115th), H.R. 1625 (115th)

Taxation/Internal Revenue Code TAX

-Issues related to H.R. 4996: "Vaccine Access Improvement Act of 2018"

LobbyistCovered position, as disclosed
BRIAN CAREY —
PAUL KIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4996 (115th)

Medicare/Medicaid MMM

-Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D

LobbyistCovered position, as disclosed
THOMAS BARKER —
BRIAN CAREY —
PAUL KIM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.